BDBM50091862 4-{(S)-5-[Bis-(4-benzyloxy-benzyl)-amino]-5-[3-(4-{3-[(R)-2-[bis-(4-benzyloxy-benzyl)-amino]-6-(4-carboxy-butyrylamino)-hexanoylamino]-propoxy}-butoxy)-propylcarbamoyl]-pentylcarbamoyl}-butyric acid::CHEMBL414551

SMILES OC(=O)CCCC(=O)NCCCC[C@@H](N(Cc1ccc(OCc2ccccc2)cc1)Cc1ccc(OCc2ccccc2)cc1)C(=O)NCCCOCCCCOCCCNC(=O)[C@H](CCCCNC(=O)CCCC(O)=O)N(Cc1ccc(OCc2ccccc2)cc1)Cc1ccc(OCc2ccccc2)cc1

InChI Key InChIKey=HNUJJBYDZDHYSV-IEPOFJRRSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 50091862   

TargetErythropoietin receptor(Homo sapiens (Human))
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50091862(4-{(S)-5-[Bis-(4-benzyloxy-benzyl)-amino]-5-[3-(4-...)
Affinity DataIC50:  4.00E+3nMAssay Description:Compound was evaluated for inhibition of [125I]-EPO binding to Erythropoietin receptor (EBP)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed